Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Person › Details

Hartmut J. Ehrlich (Abivax S.A. (Euronext Paris: ABVX))

Ehrlich, Hartmut J. (Abivax 201410 CEO before Baxter BioScience 200712 VP Global RnD)

 

Organisations Organisation Abivax S.A. (Euronext Paris: ABVX)
  Group Abivax (Group)
  Former/major organisation Baxter BioScience
  Group Baxter (Group)
Products Product therapeutic vaccine
  Product 2 virostatic agent
     

   
Record changed: 2022-09-03

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px


More documents for Hartmut J. Ehrlich


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top